Fidelity Investments’s Genesco GCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5K Buy
430
+39
+10% +$1.12K ﹤0.01% 4692
2025
Q4
$9.7K Sell
391
-42
-10% -$1.21K ﹤0.01% 4741
2025
Q3
$12.6K Sell
433
-28
-6% -$770 ﹤0.01% 4537
2025
Q2
$9.07K Sell
461
-515
-53% -$10.8K ﹤0.01% 4556
2025
Q1
$20.7K Sell
976
-161
-14% -$5.6K ﹤0.01% 4214
2024
Q4
$48.6K Buy
1,137
+143
+14% +$4.7K ﹤0.01% 3869
2024
Q3
$27K Buy
994
+69
+7% +$1.92K ﹤0.01% 4044
2024
Q2
$23.9K Sell
925
-106
-10% -$2.78K ﹤0.01% 3990
2024
Q1
$29K Buy
1,031
+91
+10% +$2.63K ﹤0.01% 3849
2023
Q4
$33.1K Sell
940
-177
-16% -$5.44K ﹤0.01% 3712
2023
Q3
$34.4K Buy
1,117
+276
+33% +$7.83K ﹤0.01% 3533
2023
Q2
$21.1K Buy
841
+209
+33% +$6.05K ﹤0.01% 3832
2023
Q1
$23.3K Sell
632
-63,131
-99% -$2.77M ﹤0.01% 3787
2022
Q4
$2.93M Sell
63,763
-83,288
-57% -$3.78M ﹤0.01% 2267
2022
Q3
$5.78M Sell
147,051
-237,506
-62% -$12.7M ﹤0.01% 2117
2022
Q2
$19.2M Sell
384,557
-532,350
-58% -$31.9M ﹤0.01% 1666
2022
Q1
$58.3M Sell
916,907
-332,467
-27% -$21.6M ﹤0.01% 1331
2021
Q4
$80.2M Sell
1,249,374
-118,760
-9% -$7.54M 0.01% 1205
2021
Q3
$79M Buy
1,368,134
+108,408
+9% +$6.45M 0.01% 1208
2021
Q2
$80.2M Buy
1,259,726
+120,284
+11% +$6.52M 0.01% 1216
2021
Q1
$54.1M Sell
1,139,442
-251,729
-18% -$10.8M ﹤0.01% 1364
2020
Q4
$41.9M Buy
1,391,171
+219,938
+19% +$5.62M ﹤0.01% 1390
2020
Q3
$25.2M Sell
1,171,233
-29,729
-2% -$582K ﹤0.01% 1474
2020
Q2
$26M Buy
1,200,962
+169,894
+16% +$3.13M ﹤0.01% 1442
2020
Q1
$13.8M Buy
1,031,068
+475,284
+86% +$16M ﹤0.01% 1569
2019
Q4
$26.6M Buy
555,784
+50
+0% +$2.07K ﹤0.01% 1489
2019
Q3
$22.2M Sell
555,734
-88
-0% -$3.4K ﹤0.01% 1533
2019
Q2
$23.5M Sell
555,822
-100,133
-15% -$4.43M ﹤0.01% 1553
2019
Q1
$29.9M Sell
655,955
-436,389
-40% -$20M ﹤0.01% 1423
2018
Q4
$48.4M Sell
1,092,344
-30,456
-3% -$1.32M 0.01% 1152
2018
Q3
$52.9M Buy
1,122,800
+95,644
+9% +$4.18M 0.01% 1248
2018
Q2
$40.8M Sell
1,027,156
-62,400
-6% -$2.66M ﹤0.01% 1381
2018
Q1
$44.2M Buy
1,089,556
+3,678
+0.3% +$136K 0.01% 1353
2017
Q4
$35.3M Buy
+1,085,878
New +$29.9M ﹤0.01% 1458
2017
Q2
Sell
-2,513,820
Closed -$139M 2638
2017
Q1
$139M Sell
2,513,820
-466,690
-16% -$27.8M 0.02% 854
2016
Q4
$185M Sell
2,980,510
-113,128
-4% -$6.9M 0.02% 710
2016
Q3
$168M Sell
3,093,638
-13,863
-0.4% -$875K 0.02% 754
2016
Q2
$200M Sell
3,107,501
-101,137
-3% -$6.69M 0.03% 659
2016
Q1
$232M Hold
3,208,638
0.03% 585
2015
Q4
$182M Sell
3,208,638
-385,774
-11% -$22.3M 0.02% 695
2015
Q3
$205M Sell
3,594,412
-5,800
-0.2% -$360K 0.03% 619
2015
Q2
$238M Sell
3,600,212
-2,200
-0.1% -$151K 0.03% 614
2015
Q1
$257M Hold
3,602,412
0.03% 578
2014
Q4
$276M Sell
3,602,412
-77,547
-2% -$5.89M 0.04% 528
2014
Q3
$275M Hold
3,679,959
0.04% 505
2014
Q2
$302M Buy
3,679,959
+293
+0% +$22.4K 0.04% 488
2014
Q1
$274M Sell
3,679,666
-2,250
-0.1% -$163K 0.04% 510
2013
Q4
$269M Sell
3,681,916
-3,250
-0.1% -$227K 0.04% 497
2013
Q3
$242M Sell
3,685,166
-8,070
-0.2% -$552K 0.04% 524
2013
Q2
$247M Buy
+3,693,236
New +$238M 0.04% 495

Other funds holding GCO

Fidelity Investments's GCO Position: Q1 2026 in Review

Fidelity Investments increased its Genesco (GCO) stake by 10% in Q1 2026, buying an estimated $1.12K and bringing the position to 430 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4692.

Fidelity Investments first reported a position in GCO in Q2 2013 and has held it in 50 quarters since. The position peaked at $302M in Q2 2014. 129 funds tracked by Wall St. Rank hold GCO as of Q1 2026.

  • Fidelity Investments held 430 shares of Genesco worth $12.5K as of Q1 2026.
  • Fidelity Investments bought 39 Genesco shares in Q1 2026, an estimated $1.12K.
  • Genesco made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4692 holding.
  • Fidelity Investments first reported a position in Genesco in Q2 2013 and has held it in 50 quarters since.
  • Fidelity Investments's Genesco position peaked at $302M in Q2 2014.
  • 129 funds tracked by Wall St. Rank held Genesco as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.